"Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. has been dedicated to the innovation and application research of Naturalization folate for sixteen years. It is the second company globally and the first in China to possess the core technology and independent intellectual property rights for active folate. As a pioneer in Naturalization folate research, it is also an international leading provider of application solutions. The company has built one of the largest patent portfolios for Naturalization folate globally.

After years of development, Jinkang Hexin has gradually formed a research and development team led by Dr. Lian Zenglin, the Chief Scientist. The research pipeline covers various areas including basic research, application research, and industrialization."